147 related articles for article (PubMed ID: 29238073)
1. Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin.
Darido C; Georgy SR; Cullinane C; Partridge DD; Walker R; Srivastava S; Roslan S; Carpinelli MR; Dworkin S; Pearson RB; Jane SM
Cell Death Differ; 2018 Jun; 25(6):1146-1159. PubMed ID: 29238073
[TBL] [Abstract][Full Text] [Related]
2. Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo.
Zou Y; Ge M; Wang X
Biochem Biophys Res Commun; 2017 Aug; 490(2):385-392. PubMed ID: 28623128
[TBL] [Abstract][Full Text] [Related]
3. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.
Darido C; Georgy SR; Wilanowski T; Dworkin S; Auden A; Zhao Q; Rank G; Srivastava S; Finlay MJ; Papenfuss AT; Pandolfi PP; Pearson RB; Jane SM
Cancer Cell; 2011 Nov; 20(5):635-48. PubMed ID: 22094257
[TBL] [Abstract][Full Text] [Related]
4. mTOR Signalling Pathway-protein Expression in Post-transplant Cutaneous Squamous-cell Carcinomas Before and After Conversion to mTOR-inhibitors.
Koletsa T; Petrakis G; Karayannopoulou G; Euvrard S; Kanitakis J
Anticancer Res; 2018 Jun; 38(6):3319-3322. PubMed ID: 29848679
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.
Georgy SR; Cangkrama M; Srivastava S; Partridge D; Auden A; Dworkin S; McLean CA; Jane SM; Darido C
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26063791
[TBL] [Abstract][Full Text] [Related]
6. PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells.
Matsumoto CS; Almeida LO; Guimarães DM; Martins MD; Papagerakis P; Papagerakis S; Leopoldino AM; Castilho RM; Squarize CH
Oncotarget; 2016 Jul; 7(27):42393-42407. PubMed ID: 27285754
[TBL] [Abstract][Full Text] [Related]
7. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
9. Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis.
Brouxhon SM; Kyrkanides S; Raja V; Silberfeld A; Teng X; Trochesset D; Cohen J; Ma L
Mol Cancer Ther; 2014 Jul; 13(7):1791-802. PubMed ID: 24748654
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
11. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
12. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
13. Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients.
Balagula Y; Kang S; Patel MJ
Photodermatol Photoimmunol Photomed; 2015 Jan; 31(1):15-25. PubMed ID: 24517835
[TBL] [Abstract][Full Text] [Related]
14. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
Zhang W; Lei C; Fan J; Wang J
Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
16. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.
Zhao M; Luo R; Liu Y; Gao L; Fu Z; Fu Q; Luo X; Chen Y; Deng X; Liang Z; Li X; Cheng C; Liu Z; Fang W
Nat Commun; 2016 Apr; 7():11309. PubMed ID: 27095304
[TBL] [Abstract][Full Text] [Related]
17. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
18. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
[TBL] [Abstract][Full Text] [Related]
19. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
20. Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
Cardnell RJ; Feng Y; Mukherjee S; Diao L; Tong P; Stewart CA; Masrorpour F; Fan Y; Nilsson M; Shen Y; Heymach JV; Wang J; Byers LA
PLoS One; 2016; 11(4):e0152584. PubMed ID: 27055253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
